Janus Henderson Group
ARQT icon

Janus Henderson Group’s Arcutis Biotherapeutics ARQT Stock Holding History

Janus Henderson Group’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.7M Buy
1,854,566
+24,505
+1% +$625K 0.02% 441
2025
Q4 		$53.2M Sell
1,830,061
-567,970
-24% -$14.5M 0.02% 403
2025
Q3 		$45.2M Buy
2,398,031
+134,071
+6% +$2.11M 0.02% 431
2025
Q2 		$31.8M Buy
2,263,960
+2,211,360
+4,204% +$31M 0.02% 478
2025
Q1 		$827K Hold
52,600
– – ﹤0.01% 1721
2024
Q4 		$732K Hold
52,600
– – ﹤0.01% 1838
2024
Q3 		$489K Hold
52,600
– – ﹤0.01% 2046
2024
Q2 		$489K Buy
+52,600
New +$476K ﹤0.01% 2000
2023
Q4 		– Sell
-22,724
Closed -$121K – 2552
2023
Q3 		$121K Buy
22,724
+9
+0% +$77 ﹤0.01% 2487
2023
Q2 		$217K Sell
22,715
-46
-0.2% -$511 ﹤0.01% 2412
2023
Q1 		$251K Buy
+22,761
New +$329K ﹤0.01% 2375

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return